Pliant Therapeutics, Inc. engages in the discovery, development and commercialization of therapies for fibrotic diseases. It offers a product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-ß1 signaling inhibition. The company was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
171
Frequently Asked Questions
What is Market Cap of Pliant Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Pliant Therapeutics Inc market cap is $97.61M.
What is the 52-week high for Pliant Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Pliant Therapeutics Inc 52 week high is $16.10 as of September 14, 2025.
What is the 52-week low for Pliant Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Pliant Therapeutics Inc 52 week low is $1.10 as of September 14, 2025.
What is Pliant Therapeutics Inc stock price today?
Pliant Therapeutics Inc stock price today is $1.59.
What was Pliant Therapeutics Inc stock price yesterday?
Pliant Therapeutics Inc stock price yesterday was $1.65.
What is the PE ratio of Pliant Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Pliant Therapeutics Inc’s P/E ratio is -0.47.
What is the Price-to-Book ratio of Pliant Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Pliant Therapeutics Inc P/B ratio is 0.4435.
What is the 50-day moving average of Pliant Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Pliant Therapeutics Inc 50-day moving average is $1.55.
How many employess does Pliant Therapeutics Inc has?